Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
Teladoc (TDOC) and Dexcom Offer New Solutions for Diabetes
02:18pm, Tuesday, 12'th Jan 2021
Teladoc (TDOC) and Dexcom jointly provide solutions for patients with Type 2 diabetes, a common lifestyle-induced malady.
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2020 and Provides Initial 2021 Outlook
07:30am, Monday, 11'th Jan 2021
SAN DIEGO--(BUSINESS WIRE)--Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2020 and Provides Initial 2021 Outlook
DexCom (DXCM) Gains But Lags Market: What You Should Know
06:48pm, Friday, 08'th Jan 2021
DexCom (DXCM) closed the most recent trading day at $388.09, moving +0.24% from the previous trading session.
3 Recession-Proof Healthcare Stocks to Buy for 2021
07:08am, Tuesday, 05'th Jan 2021
These stocks can handle whatever the new year has in store.
3 Nasdaq 100 Stocks That Can Make You a Boatload of Money in 2021
06:36am, Tuesday, 05'th Jan 2021
The highflying Nasdaq 100 is hiding some serious value in plain sight.
4 High-Growth Trends You'll Want to Invest in for 2021
06:06am, Wednesday, 30'th Dec 2020
Businesses in these fast-growing trends can shine in a young bull market.
DexCom (DXCM) Stock Sinks As Market Gains: What You Should Know
06:48pm, Thursday, 24'th Dec 2020
In the latest trading session, DexCom (DXCM) closed at $355.02, marking a -0.27% move from the previous day.
DexCom - Valuation Is A Bit Too Stretched
02:50pm, Wednesday, 23'rd Dec 2020
DexCom is an attractive company riding a long-term secular trend in the growth of chronic care management. Stock has performed well this year and is trading at the high range of historical averages.
DexCom (DXCM) Gains As Market Dips: What You Should Know
06:48pm, Friday, 18'th Dec 2020
DexCom (DXCM) closed at $358.57 in the latest trading session, marking a +0.18% move from the prior day.
Up 60% In 2020, Here's Why DexCom Is Just Getting Started
07:10am, Thursday, 17'th Dec 2020
This healthcare technology company is disrupting the diabetes market with innovative technologies that patients love.
DexCom CEO: We're more bullish about the business than we've ever been
07:31pm, Wednesday, 09'th Dec 2020
DexCom CEO Kevin Sayer reaffirms his long-term outlook for the diabetes management company, forecasting growth as high as 20% through 2025.
DexCom Has a Lot to Prove in 2021
06:12am, Wednesday, 09'th Dec 2020
Investors have a few questions as the company faces increasing competition.
3 Top Healthcare Stocks to Buy Right Now
06:24am, Sunday, 06'th Dec 2020
These companies have growth opportunities that will last long after the COVID vaccine gets life back to normal.
3 Highest-Growth Stocks in the Market Today
06:50am, Saturday, 28'th Nov 2020
These stocks could make you a fortune over the next decade.
IoMT Meets New Healthcare Needs: 3 MedTech Trends to Watch
09:07am, Friday, 27'th Nov 2020
Medical device which has for long taken tiny steps toward IoMT is now going all out to make the most of the advancements in this space amid the pandemic.
